Overview
Rectal cancer is a malignancy arising in the cells lining the rectum, the terminal segment of the large intestine. Most cases are adenocarcinomas that develop from glandular epithelium, typically progressing through the adenoma-carcinoma sequence in which benign polyps acquire successive genetic and epigenetic alterations and evolve into invasive cancer; serrated lesions represent an alternative pathway of colorectal carcinogenesis. As part of the colorectal cancer spectrum, rectal cancer shares risk factors and molecular features with colon cancer but differs in anatomical location, surgical approach, and the role of radiotherapy, owing to the rectum's confined position within the pelvis. Because early disease is often asymptomatic, screening and early detection are central to improving outcomes, and treatment commonly combines surgery with chemotherapy and radiation according to stage. Research relevant to this area examines molecular diagnostics for colorectal malignancy, including microRNA-based screening assays applied to stool, the role of nonsteroidal anti-inflammatory drugs in chemoprevention, and the pathways underlying serrated and conventional carcinogenesis. It also encompasses surgical management of the lower gastrointestinal tract and the influence of nutrition and biological aging on cancer risk. Understanding the molecular pathogenesis, screening strategies, and stage-directed treatment of rectal cancer supports earlier diagnosis and more effective, organ-appropriate management of this common gastrointestinal malignancy.
Research published in this journal
9 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Current Status of Nonsteroidal Anti-Inflammatory Drugs in Colorectal Cancer Prevention
Use of Microfluidic Assays to Develop Reliable and Economic Nucleic Acid Application Technologies, Employing MicroRNAs for the Diagnostic Screening of Colon Cancer in Human Stool in Low-Resource Settings
Use of Microfluidic Assays to Develop Reliable and Economic Nucleic Acid Application Technologies, Employing MicroRNAs for the Diagnostic Screening of Colon Cancer in Human Stool in Low-Resource Settings
Serrated Lesions of Colorectum: A New Pathway in Colorectal Carcinogenesis
Oxidative Telomere Attrition, Nutritional Antioxidants and Biological Aging
Restoration of Bowel Continuity After Emergency Hartmann’s Procedure
Application of a Cardiac Septal Occluder in a Patient Affected by Enteroatmospheric Fistula
Epigenetics and Nutrition
How this research is being cited
The 9 articles above have been cited 37 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Diagnostic and Therapeutic Potential of Selected microRNAs in Colorectal Cancer: A Literature Review2025 · Cancers
-
Diagnostic and Therapeutic Potential of Selected microRNAs in Colorectal Cancer: A Literature Review2025 · Cancers
-
2024 · Current Signal Transduction Therapy
-
2024 · Diagnostics
-
2024 · Diagnostics
-
2024 · Current Signal Transduction Therapy
-
2023 · Biosensors
-
2023 · Expert Review of Molecular Diagnostics
A sample of recent works citing this journal's research on Rectal Cancer, linking to each citing work.